BioSpace News Archive

Ossur Hf : Transactions in Relation to Share Buyback Program - Jan. 29, 2018

On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017.

January 29, 2018
·
2 min read
Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent

The EPO Opposition Division revoked the ’355 patent after considering third-party oppositions from several opponents

January 29, 2018
·
4 min read
Business

STORM Therapeutics Appoints Distinguished Professor and Nobel Prize Winner Professor Thomas Cech as Scientific Advisor

This appointment follows STORM Therapeutics’ successful Series A Financing Extension announced in January 2018.

January 29, 2018
·
2 min read
SBRI Healthcare Alumni Company Owlstone Medical Wins Global IPF Catalyst Challenge

SBRI Healthcare is delighted to congratulate Owlstone Medical on being named one of three winners of the global Idiopathic Pulmonary Fibrosis Catalyst Challenge.

January 29, 2018
·
2 min read
Genetown

Waters BioResolve RP mAb Polyphenyl Columns, Setting a New Standard for Reversed-Phase Separations of Monoclonal Antibodies and Antibody Drug Conjugates

Waters Corporation today introduced BioResolve RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS.

January 29, 2018
·
5 min read
Drug Development

Yale University Release: PAT-DX1-NP Localizes to Lymph Node Metastases

Patrys Limited is pleased to announce further pre-clinical data for its drug candidate PATDX1-NP.

January 29, 2018
·
3 min read
Drug Development

Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit

The presentation is scheduled for 2:15 pm Eastern Time on February 1, 2018.

January 29, 2018
·
4 min read
FDA

CardiAMP Cell Therapy Receives FDA Approval for Pivotal Trial in Chronic Myocardial Ischemia

The trial has been approved to enroll up to 343 subjects at up to 40 U.S. centers.

January 29, 2018
·
4 min read
Business

Almac Group Appoints Dr. Stefan Mix as Head of Biocatalysis

In his new role, Stefan, who is the author of several publications will be responsible for the development and application of platform technologies within Almac Sciences leading a team of almost 50 scientists, in addition to supporting and directing commercialisation of new technology.

January 29, 2018
·
1 min read
SafeHeal Starts First-in-Human and CE-Mark Clinical Study of Endoluminal Bypass Sheath With the Potential of Replacing Ostomy

SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announces today that it has enrolled the first five patients in its CE mark study.

January 29, 2018
·
4 min read